WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
French sports minister calls for sanctions after Monaco player tapes over anti
Armed men kidnap a senior judge in Pakistan’s restive northwest
Ancient villages boost tourism by innovation in Hebei
Dubai plans to move its busy international airport to a $35 billion new facility within 10 years
Hall of Fame outfielder Ken Griffey Jr. to lead Indianapolis 500 field in Corvette pace car
Crowding recurs at the Universal Beijing Resort
Spring Festival spending highlights momentum of China's economy
Int'l travel expo kicks off in Macao
Kevin Pillar gets 1,000th career hit in Angels' win at Texas
Climate change blamed for heavy rain in the south
Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
PLA's information support force is brand